Clinical Trial Update: Radiation Therapy With Cisplatin or Cetuximab in Treating Patients With Oropharyngeal Cancer [Phase 3]

View source ↗

Summary

A Phase 3 trial comparing radiation therapy with cisplatin versus cetuximab in patients with oropharyngeal cancer has completed enrollment and posted results in…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Head and Neck Cancer
• Oropharyngeal Cancer

Drugs mentioned

• ERBITUX (cetuximab)
• Platinol (cisplatin)

Snippet

Sponsor: Radiation Therapy Oncology Group | Conditions: Head and Neck Cancer, Precancerous Condition | Phase 3 | Status: COMPLETED | Results posted: 2020-01-09